Skip to main content

Advertisement

Log in

Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23)

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). A total of 153 patients with breast cancer and 153 normal subjects completed three questionnaires of the Korean version of the EORTC QLQ-BR23. Multitrait scaling analyses demonstrated that all scales met multidimensional conceptualization criteria in terms of convergence and discrimination validity. Cronbach’s alpha coefficients for five multiple-item scales were greater than 0.70 (range, 0.72–0.91). In known-group comparisons, there were marked group differences between patients differing in disease stage. In breast cancer patients, performance on the questionnaires was in the expected direction for almost all functioning and symptom scores. In addition, comparison between the patient and control groups showed that almost all variables discriminated between patients and normal individuals. In conclusion, the Korean version of the EORTC QLQ-BR23 was found to be a reliable and valid measure of quality of life in breast cancer patients, indicating that it should be used in clinical and epidemiological cancer research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bowling A (1995) What things are important in people’s lives? A survey of the public’s judgements to inform scales of health related quality of life. Soc Sci Med 41:1447–1462

    Article  CAS  PubMed  Google Scholar 

  2. Brady MJ, Cella DF, Mo F, et al (1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15:974–986

    CAS  PubMed  Google Scholar 

  3. Cella DF, Tulsky DS, Gray G, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579

    CAS  PubMed  Google Scholar 

  4. Cronbach LJ (1951) Coeffecient alpha and the internal structure of tests. Psychomrtrika 16:297–334

    Google Scholar 

  5. Fayers P, Aaronson N, Bjordal K, Sullivan M (1995) EORTC-C30 scoring manual. EORTC study group on quality of life, Brussels

  6. Levine MN, Guyatt GH, Gent M, et al (1988) Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol 6:1798–1810

    CAS  PubMed  Google Scholar 

  7. Love RR, Leventhal H, Easterling DV, Nerenz DR (1989) Side effects and emotional distress during cancer chemotherapy. Cancer 63:604–612

    CAS  PubMed  Google Scholar 

  8. Macleod CM (ed) (1949) Evaluation of chemotherapeutic agents. Columbia University Press, New York

  9. Montazeri A, Harirchi I, Vahdani M, et al (2000) The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res 9:177–184

    Article  CAS  PubMed  Google Scholar 

  10. Nunnally JC (1994) Psychometric theory. McGraw-Hill, New York

  11. Shin HR, et al (2002) Cancer incidence in Korea. Cancer research and treatment 34(6):405–408

    Google Scholar 

  12. Sprangers MA, Groenvold M, Arraras JI, et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756–2768

    CAS  PubMed  Google Scholar 

  13. Stewart BW and Kleihues P (eds) (2003) World cancer report. IARC Press. World Health Organization. Lyon, France

  14. Zubord CG, Scheiderman MA, Frei E (1960) Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiopphosphoramide. J Chro Dis 11:7–33

    Google Scholar 

Download references

Acknowledgements

This work was supported by a National Cancer Center Grant (0110030–3). We thank the EORTC Study Group on Quality of Life for their permission to translate the EORTC QLQ-BR23. We are especially grateful for the help received from Ms. Karen West of the EORTC Quality of Life Unit.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eun Sook Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yun, Y.H., Bae, S.H., Kang, I.O. et al. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). Support Care Cancer 12, 441–445 (2004). https://doi.org/10.1007/s00520-004-0632-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-004-0632-3

Keywords

Navigation